Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Toward ethically responsible choice architecture in prostate cancer treatment decision-making.

Literature DB >> 25998159

Toward ethically responsible choice architecture in prostate cancer treatment decision-making.

J S Blumenthal-Barby¹, Denise Lee², Robert J Volk³.

Abstract

Entities: Disease Species

Mesh：

Year: 2015 PMID： 25998159 PMCID： PMC4825318 DOI： 10.3322/caac.21283

Source DB: PubMed Journal: CA Cancer J Clin ISSN： 0007-9235 Impact factor: 508.702

× No keyword cloud information.

38 in total

1. (Almost) everything you ever wanted to know about informed consent. [Review of: Faden, RR and Beauchamp, TL. A history and theory of informed concsent. New York and Oxford: Oxford University Press, 1986].

Authors: A M Capron
Journal: Med Humanit Rev Date: 1987-01

2. Designing Normative Messages About Active Surveillance for Men With Localized Prostate Cancer.

Authors: Robert J Volk; Gianna T Kinsman; Yen-Chi L Le; Paul Swank; Jennifer Blumenthal-Barby; Stephanie L McFall; Theresa L Byrd; Patricia Dolan Mullen; Scott B Cantor
Journal: J Health Commun Date: 2015-06-11

3. Making decisions about treatment for localized prostate cancer.

Authors: S K Steginga; S Occhipinti; R A Gardiner; J Yaxley; P Heathcote
Journal: BJU Int Date: 2002-02 Impact factor: 5.588

4. National trends in the management of low and intermediate risk prostate cancer in the United States.

Authors: Adam B Weiner; Sanjay G Patel; Ruth Etzioni; Scott E Eggener
Journal: J Urol Date: 2014-08-05 Impact factor: 7.450

Review 5. Decision aids for people facing health treatment or screening decisions.

Authors: Dawn Stacey; France Légaré; Nananda F Col; Carol L Bennett; Michael J Barry; Karen B Eden; Margaret Holmes-Rovner; Hilary Llewellyn-Thomas; Anne Lyddiatt; Richard Thomson; Lyndal Trevena; Julie H C Wu
Journal: Cochrane Database Syst Rev Date: 2014-01-28

6. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.

Authors: Anna Bill-Axelson; Hans Garmo; Lars Holmberg; Jan-Erik Johansson; Hans-Olov Adami; Gunnar Steineck; Eva Johansson; Jennifer R Rider
Journal: Eur Urol Date: 2013-02-26 Impact factor: 20.096

7. Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study.

Authors: Richard M Hoffman; William C Hunt; Frank D Gilliland; Robert A Stephenson; Arnold L Potosky
Journal: Cancer Date: 2003-04-01 Impact factor: 6.860

Toward ethically responsible choice architecture in prostate cancer treatment decision-making.

1. (Almost) everything you ever wanted to know about informed consent. [Review of: Faden, RR and Beauchamp, TL. A history and theory of informed concsent. New York and Oxford: Oxford University Press, 1986].

2. Designing Normative Messages About Active Surveillance for Men With Localized Prostate Cancer.

3. Making decisions about treatment for localized prostate cancer.

4. National trends in the management of low and intermediate risk prostate cancer in the United States.

Review 5. Decision aids for people facing health treatment or screening decisions.

6. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.

7. Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study.

8. Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications.

9. Patients' and urologists' preferences for prostate cancer treatment: a discrete choice experiment.

Review 10. Do personal stories make patient decision aids more effective? A critical review of theory and evidence.

1. A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer.

2. Choice architecture in physician-patient communication: a mixed-methods assessments of physicians' competency.